UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 613

Sortiert nach

Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis

Leukemia, 2016-12, Vol.30 (12), p.2385-2395

2016

Volltextzugriff (PDF)

A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma

Leukemia, 2014-05, Vol.28 (5), p.1092-1102

2014

Volltextzugriff (PDF)

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

Journal of clinical pathology, 2009-07, Vol.62 (7), p.613-616

2009

Volltextzugriff (PDF)

Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor

Leukemia, 2014-09, Vol.28 (9), p.1937-1940

2014

Volltextzugriff (PDF)

Quality assurance trials for Ki67 assessment in pathology

Virchows Archiv : an international journal of pathology, 2017-10, Vol.471 (4), p.501-508

2017

Volltextzugriff (PDF)

MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma

Leukemia, 2013-06, Vol.27 (6), p.1381-1390

2013

Volltextzugriff (PDF)

Selective deletion of Jak2 in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia

Haematologica (Roma), 2014-04, Vol.99 (4), p.e52

2014

Volltextzugriff (PDF)

The novel BTK and PI3K-delta inhibitors acalabrutinib (ACP-196) and ACP-319 show activity in pre-clinical B-cell lymphoma models

European journal of cancer (1990), 2016-12, Vol.69, p.S39-S40

2016

Volltextzugriff (PDF)

Diagnostic and prognostic utility of PD-1 in B cell lymphomas

Disease markers, 2010, Vol.29 (1), p.47-53

2010

Volltextzugriff (PDF)

Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment

Journal of clinical pathology, 2009-08, Vol.62 (8), p.754-756

2009

Volltextzugriff (PDF)

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

Journal of clinical pathology, 2004-09, Vol.57 (9), p.965-969

2004

Volltextzugriff (PDF)

GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.715-721

2013

Volltextzugriff (PDF)

Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus

European journal of surgical oncology, 2010-07, Vol.36 (7), p.670-677

2010

Volltextzugriff (PDF)

SAKK 36/13 ‐ IBRUTINIB PLUS BORTEZOMIB AND IBRUTINIB MAINTENANCE FOR RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: FINAL REPORT OF A PHASE I/II TRIAL OF THE EUROPEAN MCL NETWORK

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Patterns of liver infiltration in lymphoproliferative disease

Histopathology, 2008-07, Vol.53 (1), p.81-90

2008

Volltextzugriff (PDF)

WHOLE‐EXOME‐SEQUENCING OF NODAL MARGINAL ZONE LYMPHOMAS IDENTIFIES RECURRENT MOLECULAR LESIONS IN GENES INVOLVED IN CHROMATIN REMODELLING AND NOTCH SIGNALLING

Hematological oncology, 2017-06, Vol.35 (S2), p.149-149

2017

Volltextzugriff (PDF)

INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC HETEROGENEITY PREDICTS OUTCOME OF DLBCL LYMPHOMA PATIENTS IN THE SAKK 38/07 STUDY COHORT

Hematological oncology, 2019-06, Vol.37 (S2), p.77-78

2019

Volltextzugriff (PDF)

Clonal relationship of relapsing lymphoid neoplasms

Histology and histopathology, 2012-08, Vol.27 (8), p.1013

2012

Volltextzugriff (PDF)

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

Journal of clinical pathology, 2013-11, Vol.66 (11), p.956-961

2013

Volltextzugriff (PDF)

PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICULAR LYMPHOMA UNDER RITUXIMAB AND RITUXIMAB+LENALIDOMIDE THERAPY. A TRANSLATIONAL STUDY OF THE SAKK35/10 TRIAL

Hematological oncology, 2019-06, Vol.37 (S2), p.149-151

2019

Volltextzugriff (PDF)

CHARACTERIZATION OF MEDIASTINAL LYMPHOMAS IN FEMALE SIBLINGS AND IDENTIFICATION OF TIRAP AS A NOVEL LYMPHOMA RISK GENE

Hematological oncology, 2017-06, Vol.35 (S2), p.161-162

2017

Volltextzugriff (PDF)

SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS

Hematological oncology, 2019-06, Vol.37 (S2), p.118-119

2019

Volltextzugriff (PDF)

BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma

Journal of clinical pathology, 2009-10, Vol.62 (10), p.903-907

2009

Volltextzugriff (PDF)

Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer

European journal of surgical oncology, 2009-12, Vol.35 (12), p.1268-1272

2009

Volltextzugriff (PDF)

CD5 expression in de novo diffuse large B-cell lymphomas

Annals of oncology, 2009-04, Vol.20 (4), p.789-790

2009

Volltextzugriff (PDF)

1 – 25 von 613

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(529)
Mit Volltextzugriff
(502)

Publikationsform

Sprache

Englisch
(555)
Japanisch
(104)
Deutsch
(59)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis

A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor

Quality assurance trials for Ki67 assessment in pathology

MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma

Selective deletion of Jak2 in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia

The novel BTK and PI3K-delta inhibitors acalabrutinib (ACP-196) and ACP-319 show activity in pre-clinical B-cell lymphoma models

Diagnostic and prognostic utility of PD-1 in B cell lymphomas

Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM

Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus

SAKK 36/13 ‐ IBRUTINIB PLUS BORTEZOMIB AND IBRUTINIB MAINTENANCE FOR RELAPSED AND REFRACTORY MANTLE CELL LYMPHOMA: FINAL REPORT OF A PHASE I/II TRIAL OF THE EUROPEAN MCL NETWORK

Patterns of liver infiltration in lymphoproliferative disease

WHOLE‐EXOME‐SEQUENCING OF NODAL MARGINAL ZONE LYMPHOMAS IDENTIFIES RECURRENT MOLECULAR LESIONS IN GENES INVOLVED IN CHROMATIN REMODELLING AND NOTCH SIGNALLING

INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC HETEROGENEITY PREDICTS OUTCOME OF DLBCL LYMPHOMA PATIENTS IN THE SAKK 38/07 STUDY COHORT

Clonal relationship of relapsing lymphoid neoplasms

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

PROGNOSTIC IMPLICATIONS OF THE MICROENVIRONMENT IN FOLLICULAR LYMPHOMA UNDER RITUXIMAB AND RITUXIMAB+LENALIDOMIDE THERAPY. A TRANSLATIONAL STUDY OF THE SAKK35/10 TRIAL

CHARACTERIZATION OF MEDIASTINAL LYMPHOMAS IN FEMALE SIBLINGS AND IDENTIFICATION OF TIRAP AS A NOVEL LYMPHOMA RISK GENE

SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS

BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma

Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer

CD5 expression in de novo diffuse large B-cell lymphomas

Suchergebnisse filtern